We are live on ! Find out more
AEPBI

AH Equity Partners Bio II Portfolio holdings

AUM $144M
1-Year Est. Return 54.61%
This Fund
S&P 500
This Quarter Est. Return
-30.38%
1 Year Est. Return
-54.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$192M
AUM Growth
–
Cap. Flow
+$320M
Cap. Flow %
166.6%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EQRX
EQRx, Inc. Common Stock
EQRX
+$165M
2
NAUT icon
Nautilus Biotechnolgy
NAUT
+$87.2M
3
ERAS icon
Erasca
ERAS
+$42.8M
4
NVTA
Invitae Corporation
NVTA
+$25.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 90.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$119M 61.93%
+17,438,465
New +$165M
ERAS icon
2
Erasca
ERAS
$6.63B
$39M 20.28%
+2,500,000
New +$42.8M
NVTA
3
DELISTED
Invitae Corporation
NVTA
$17.9M 9.3%
+1,170,127
New +$25.3M
NAUT icon
4
Nautilus Biotechnolgy
NAUT
$215M
$16.3M 8.49%
+16,298,006
New +$87.2M

Similar funds

JAMH
Junson Asset Management (HK) Hong Kong $147M AUM 33.59% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
HGM
Highside Global Management Dallas, Texas $136M AUM 36.73% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
SP
StackLine Partners New York $134M AUM 35.15% 1-Year Est. Return
SC
Siena Capital Cincinnati, Ohio $153M AUM 9% 1-Year Est. Return
SCM
Salem Capital Management Woburn, Massachusetts $126M AUM 8.82% 1-Year Est. Return

AH Equity Partners Bio II's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for AH Equity Partners Bio II, which disclosed 4 positions worth $192M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is EQRx, Inc. Common Stock: 17,438,465 shares worth $119M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets.

  • AH Equity Partners Bio II's largest Q4 2021 buy was EQRx, Inc. Common Stock: 17,438,465 shares worth $119M.
  • AH Equity Partners Bio II's ten largest holdings make up 100% of its $192M portfolio in Q4 2021.
  • AH Equity Partners Bio II disclosed 4 positions in Q4 2021, its first 13F filing on record.

Based on AH Equity Partners Bio II's 13F filing for Q4 2021, filed 14 Feb 2022.